Kuros Biosciences

Kuros Biosciences is a Swiss-based biopharmaceutical company focused on developing innovative products for tissue repair and bone regeneration. The pharmaceutical segment includes products such as fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation by inducing the differentiation of bone progenitor cells, enhancing osteoblast proliferation, and increasing the lifespan of bone-forming cells. The legacy portfolio segment includes all other parts.